drugset / Trial / NCT00242333

A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD

NCT00242333

Phase 2 Completed 300 enrolled Sosei Novartis · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the efficacy, safety and tolerability of AD 237 in patients with chronic obstructive pulmonary disease (COPD).

Timeline

Start
2005-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate Small molecule Inhaled